Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops innovative RNAi-based therapeutics to treat diseases by silencing causative genes. Arrowhead is committed to advancing cardiometabolic research for patients who have diseases with significant unmet needs.